IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 165 filers reported holding IMPAX LABORATORIES INC in Q4 2013. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,150,000 | +78.6% | 69,052 | +42.1% | 0.00% | +50.0% |
| Q4 2016 | $644,000 | -50.0% | 48,578 | +20.7% | 0.00% | -50.0% |
| Q1 2016 | $1,289,000 | +83.6% | 40,253 | +145.2% | 0.00% | +100.0% |
| Q4 2015 | $702,000 | -65.8% | 16,414 | -71.9% | 0.00% | -66.7% |
| Q3 2015 | $2,054,000 | -39.7% | 58,347 | -21.4% | 0.01% | -33.3% |
| Q2 2015 | $3,408,000 | +94.3% | 74,225 | +98.3% | 0.01% | +80.0% |
| Q1 2015 | $1,754,000 | -3.7% | 37,429 | -38.4% | 0.01% | -37.5% |
| Q2 2014 | $1,822,000 | -41.1% | 60,757 | -48.1% | 0.01% | -42.9% |
| Q1 2014 | $3,093,000 | +1098.8% | 117,076 | +827.3% | 0.01% | +1300.0% |
| Q3 2013 | $258,000 | – | 12,625 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
| Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
| Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
| Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
| NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
| Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |